ALOX5AP expression is increased in patients of obesity and insulin resistance (Elias et al., 2016) and recognized as a susceptibility gene for stroke (Papapostolou et al., 2014), but its role in cancer genesis and progression has not been investigated. The gene discussed is ALOX5AP; the disease is obesity due to melanocortin 4 receptor deficiency.